Vor Bio Rallies On Strong Data For Autoimmune Drug Candidate

benzinga.com/news/health-care/25/08/47095146/vor-bio-rallies-on-strong-data-for-autoimmune-drug-candidate

Vor Bio (NASDAQ:VOR) stock is trading higher on Wednesday with a session volume of 10.83 million compared to the average volume of 17.99 million, as per data from Benzinga Pro.
The clinical-stage biotechnology focused on autoimmune diseases announced that its collaborator, RemeGen Co.…

This story appeared on benzinga.com, 2025-08-13 15:15:06.
The Entire Business World on a Single Page. Free to Use →